… Inhibitors Chris Martin +more Sep 09, 2025 Press release Circulating Tumor DNA May Guide Immunotherapy Use in Limited-Stage SCLC, New …

… NSCLC Haleigh Behrman Nov 04, 2025 ILCN article Using Early ctDNA, Study Findings Inform Prognostic Model Haleigh Behrman … JTO The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015 Ming S. Tsao +more Nov …

… JTO The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015 Ming S. Tsao +more Nov … JTO The 2021 World Health Organization Classification of Tumors of the Thymus and Mediastinum: What’s new in thymic epithelial, germ cell and mesenchymal tumors? A. Marx +more Oct 21, 2021 Explore Our Journals …

… for Research and Education Brazil Project:  Genome-wide DNA Methylation Analysis in Patients with EFGR-mutant Lung … Project: Targeting Phagocytosis Regulators to Enhance Anti-Tumor Immunity in Small Cell Lung Cancer     Image Komal … States Project:  Development of a Gene Signature Linking Tumor-Reactive TIL Spatial Interactions Related to …

… non-small cell lung cancer (NSCLC). Her pioneering work on DNA damage response (DDR) pathways and immune activation … Multiple Myeloma program, a Lymphoma Program, a functional tumor registry, an Integrated Breast & Cervical Cancer … work on non-invasive molecular subtyping of NSCLC based on circulating tumor DNA established the foundation for liquid …

… of lung cancers harboring mutations in genes involved in DNA damage repair (DDR) derive improved clinical … of the interaction of metabolite-miRNA in driving tumor initiation. Read Spotlight Grant Recipient Hua Zhang, …

… Multiple Myeloma program, a Lymphoma Program, a functional tumor registry, an Integrated Breast & Cervical Cancer … non-small cell lung cancer (NSCLC). Her pioneering work on DNA damage response (DDR) pathways and immune activation … work on non-invasive molecular subtyping of NSCLC based on circulating tumor DNA established the foundation for liquid …

… liquid biopsies, specifically in extracellular vesicles and circulating free tumor DNA.   Dr. Rolfo has authored more than 250 scientific …

… Multiple Myeloma program, a Lymphoma Program, a functional tumor registry, an Integrated Breast & Cervical Cancer … non-small cell lung cancer (NSCLC). Her pioneering work on DNA damage response (DDR) pathways and immune activation … work on non-invasive molecular subtyping of NSCLC based on circulating tumor DNA established the foundation for liquid …

… Multiple Myeloma program, a Lymphoma Program, a functional tumor registry, an Integrated Breast & Cervical Cancer … evaluating nivolumab for patients with thymic epithelial tumor and currently engaging multimodality therapy for … non-small cell lung cancer (NSCLC). Her pioneering work on DNA damage response (DDR) pathways and immune activation …

… work on non-invasive molecular subtyping of NSCLC based on circulating tumor DNA established the foundation for liquid biopsy as a …